Unknown

Dataset Information

0

Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration.


ABSTRACT: Parkinson's disease (PD) is a neurodegenerative disorder of uncertain pathogenesis characterized by the loss of the nigrostriatal dopaminergic neurons, which can be modeled by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Increased expression of cyclooxygenase type 2 (COX-2) and production of prostaglandin E(2) have been implicated in neurodegeneration in several pathological settings. Here we show that COX-2, the rate-limiting enzyme in prostaglandin E(2) synthesis, is up-regulated in brain dopaminergic neurons of both PD and MPTP mice. COX-2 induction occurs through a JNKc-Jun-dependent mechanism after MPTP administration. We demonstrate that targeting COX-2 does not protect against MPTP-induced dopaminergic neurodegeneration by mitigating inflammation. Instead, we provide evidence that COX-2 inhibition prevents the formation of the oxidant species dopamine-quinone, which has been implicated in the pathogenesis of PD. This study supports a critical role for COX-2 in both the pathogenesis and selectivity of the PD neurodegenerative process. Because of the safety record of the COX-2 inhibitors, and their ability to penetrate the blood-brain barrier, these drugs may be therapies for PD.

SUBMITTER: Teismann P 

PROVIDER: S-EPMC154369 | biostudies-literature | 2003 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration.

Teismann Peter P   Tieu Kim K   Choi Dong-Kug DK   Wu Du-Chu DC   Naini Ali A   Hunot Stéphane S   Vila Miquel M   Jackson-Lewis Vernice V   Przedborski Serge S  

Proceedings of the National Academy of Sciences of the United States of America 20030417 9


Parkinson's disease (PD) is a neurodegenerative disorder of uncertain pathogenesis characterized by the loss of the nigrostriatal dopaminergic neurons, which can be modeled by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Increased expression of cyclooxygenase type 2 (COX-2) and production of prostaglandin E(2) have been implicated in neurodegeneration in several pathological settings. Here we show that COX-2, the rate-limiting enzyme in prostaglandin E(2) synthesis, is up-  ...[more]

Similar Datasets

| S-EPMC327205 | biostudies-literature
| S-EPMC7410064 | biostudies-literature
| S-EPMC4037122 | biostudies-literature
| S-EPMC4563670 | biostudies-other
| S-EPMC7470775 | biostudies-literature
| S-EPMC9497016 | biostudies-literature
| S-EPMC9990146 | biostudies-literature
| S-EPMC9149120 | biostudies-literature
| S-EPMC8629119 | biostudies-literature
| S-EPMC8041043 | biostudies-literature